Post
Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device
June 8, 2016
Press Release:
Spaulding Medical, LLC announced the FDA 510(k) Clearance for their newest 12-Lead ECG device – the Spaulding Electrocardiograph 2100iQ™.
The wireless, hand-held cardiac safety medical device was designed to streamline and improve the collection of real-time data of ECG data via Bluetooth™ for doctors and patients.
Managed entirely in the Cloud, the Spaulding Electorcardiograph 2100iQ™ mission is to deliver high-quality data in less time and at a reduced cost.
With the FDA 510(k) Clearance ready, Spaulding Clinical Research, LLC has strengthened their commitment to being an innovation leader in cardiac safety solutions.